Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis

Virus Research

Volumn 163, Issue 2, 2012, Pages 424-430

  Jankosky, Christopher ^a   Deussing, Eric ^a   Gibson, Roger L ^a   Haverkos, Harry W ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Enteroviruses; Herpesviruses; Multiple sclerosis; Sufficient component causal model; Type 1 diabetes mellitus; Vitamin D deficiency

Indexed keywords

CALCITRIOL; CARBOHYDRATE; CYP24A1; CYP27B1; CYTOCHROME; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; MYELIN BASIC PROTEIN; NITROSAMINE; UNCLASSIFIED DRUG; VITAMIN D;

ADAPTIVE IMMUNITY; CARDIOVIRUS; CROSS REACTION; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FOLLOW UP; HEREDITY; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; JC VIRUS; JUVENILE DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; VARICELLA ZOSTER VIRUS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS INFECTIONS; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; VITAMIN D DEFICIENCY;

ENTEROVIRUS; HERPESVIRIDAE;

EID: 84856539377     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.11.010     Document Type: Review

References (102)

1. Adams S.F. The seasonal variation in the onset of acute diabetes. Arch. Intern. Med. 1926, 37:861-864.
2. Alter M., Kahana E., Loewenson R. Migration and risk of multiple sclerosis. Neurology 1978, 28:1089-1093.
3. Alter M., Leibowitz U., Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch. Neurol. 1966, 15:234-237.
4. Anderson D.W., Ellenberg J.H., Leventhal C.M., Reingold S.C., Rodriguez M., Silberberg D.H. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann. Neurol. 1992, 31:333-336.
5. ANZgene (The Australian and New Zealand Multiple Sclerosis Genetics Consortium) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41(7):824-828.
6. Ascherio A.M., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 2007, 61:288-299.
7. Ascherio A., Munger K.L., Lennette E.T., Splegelman D., Hernan M.A., Olek M.J., Hankinson S.E., Hunter D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001, 286:3083-3088.
8. Ascherio A., Munger K.L. Epstein-Barr virus infection and multiple sclerosis: a review. J. Neuroimmmune Pharmacol. 2010, 5:271-277.
9. Ashitey G.A., Millar J.H. Multiple sclerosis in Northern Ireland. A study of the date and place of birth of patients. Ulster. Med. J. 1970, 39:55-63.
10. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
11. Baum J.D., Ounsted M., Smith M.A. Weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet 1975, 2:866.
12. Bergstrom T. Herpesvirus-a rationale for antiviral treatment in multiple sclerosis. Antiviral Res. 1999, 41:1-19.
13. Bikle D.D. Vitamin D and immune function: understanding common pathways. Curr. Osteopor. Rep. 2009, 7:58-63.
14. Blohme G., Nystrom L., Arnqvist H.J., Lithner F., Littorin B., Olsson P.O., Schersten B., Wibell L., Ostman J. Male predominance of Type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34-year age group in Sweden. Diabetologia 1992, 35:56-72.
15. Blom L., Persson L.A., Dahlquist G. A high linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 1992, 35:528-533.
16. Cantorna M.T., Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. 2004, 229:1136-1142.
17. Challoner P.B., Smith K.T., Parker J.D., MacLean D.L., Coulter S.N., Rose T.M., Schulz E.R., Bennett J.L., Garber R.L., Chang M., et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7440-7444.
18. Chiu K.C., Chu A., Go V.L.W., Saad M.F. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am. J. Clin. Nutr. 2004, 79:820-825.
19. Cho J.H., Gregersen P.K. Genomic medicine: genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 2011, 365:1612-1623.
20. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
21. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
22. Concannon P., Rich S.S., Neporn G.T. Genetics of type 1A diabetes. N. Engl. J. Med. 2009, 360:1646-1654.
23. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., Todd J.A., Rich S.S. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54:2995-3001. the Type 1 Diabetes Genetics Consortium.
24. Craighead J.E., McLane M.F. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968, 162:913-914.
25. Dahlquist G., Blom L., Lonnberg G. The Swedish Childhood Diabetes Study-a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 1991, 34:757-762.
26. Dahlquist G.G., Blom L.G., Persson L-A., Sandstrom A.I.M., Wall S.G.I. Dietary factors and the risk of developing insulin dependent diabetes in childhood. Br. Med. J. 1990, 300:1302-1306.
27. Delogu L.G., Deidda S., Delitala G., Manetti R. Infectious diseases and autoimmunity. J. Infect. Dev. Ctries. 2011, 5:679-687.
28. Donati D., Jacobson S. Viruses and MS. Polymicrobial Diseases 2002, 99-124. ASM Press, Washington, DC, (Chapter 6). K.A. Brogden, J.M. Guthmiller (Eds.).
29. Dorner G., Thoelke H., Mohnike A., Schneider H. High food supply in perinatal life appears to favour the development of insulin-treated diabetes mellitus (ITDM) in later life. Exp. Clin. Endocrinol. 1985, 85:1-6.
30. Eisenbarth G.S. Update in type 1 diabetes. J. Clin. Endocrinol. Metab. 2007, 92:2403-2407.
31. Elliott, R.B., 1992. Epidemiology of diabetes in Polynesia and New Zealand. In: Levy-Marchal, C., Czernidhow, P. (Eds.), Epidemiology and Etiology of Insulin-dependent Diabetes Mellitus in the Young, Karger: Basel. Pediatr. Adolesc. Endocrinol. 21, 66-71.
32. Evans A.S. Limitations of Koch's postulates. Lancet 1977, 2:1277-1278.
33. Evans A.S., Mueller N.E. Viruses and cancer. Causal associations. Ann. Epidemiol. 1990, 1:71-92.
34. Fotheringham J., Jacobson S. Human herpes 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes 2005, 12:4-9.
35. Fraser K.B., Haire M., Millar J.H., McCrea S. Increased tendency to spontaneous in vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet 1979, 2:175-176.
36. Goodin D.S. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS ONE 2009, 4(2):e4565.
37. Griffin M.D., Xing N., Kumar R. Vitamin d and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 2003, 23:117-145.
38. Handel A.E., Disanto G., Jarvis L., McLaughlin R., Fries A., Ebers G.C., Ramagopalan S.V. Seasonality of admissions with multiple sclerosis. Eur. J. Neurol. 2011, 18:1109-1111.
39. Hart P.H., Gorman S., Finlay-Jones J.J. Modulation of the immune system by UV radiation: more than just the effects of vitamin D?. Nat. Rev. Immunol. 2011, 11:584-596.
40. Haverkos H.W. Could the aetiology of IDDM be multifactorial?. Diabetologia 1997, 40:1235-1240.
41. Haverkos H.W., Battula N., Drotman D.P., Rennert O.M. Enteroviruses and type 1 diabetes mellitus. Biomed. Pharmacother. 2003, 57:379-385.
42. Hawkes C.H., Macgregor A.J. Twin studies and the heritability of MS: a conclusion. Mult. Scler. 2009, 15:661-667.
43. Hayes C.E., Nashold F.E., Spach K.M., Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. 2003, 49:277-300.
44. Hayes C.E., Acheson D.E. The unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Med. Hypotheses 2008, 71:85-90.
45. Helfand R.F., Gary H.E., Freeman C.Y., Anderson L.J., Pittsburg Diabetes Research Group, Pallansch M.A. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. J. Infect. Dis. 1995, 172:1206-1211.
46. Hollick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
47. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
48. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2 et al., 2011. Genetic risk and primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219.
49. Jacobson S. Association of human herpesvirus-6 and multiple sclerosis: here we go again?. J. Neurovirol. 1998, 4:471-473.
50. Kalits I., Podar T. Incidence and prevalence of type 1 (insulin-dependent) diabetes in Estonia in 1988. Diabetologia 1990, 33:346-349.
51. Kampman M.T., Wilsgaard T., Mellgren S.I. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J. Neurol. 2007, 254:471-477.
52. Kim N.H., Kim H.J., Cheong H.K., Kim B.J., Lee K.H., Kim E.H., Kim E.A., Kim S., Park M.S., Yoon W.T. Prevalence of multiple sclerosis in Korea. Neurology 2010, 75:1432-1438. Korean Multiple Sclerosis Study Group.
53. Koch-Henriksen N., Sorensen P.S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010, 9(5):520-532.
54. Kurland L.T. Epidemiologic characteristics of multiple sclerosis. Am. J. Med. 1952, 12:561-571.
55. Kurtzke J.F. An epidemiologic approach to multiple sclerosis. Arch. Neurol. 1966, 14:213-222.
56. Kurtzke J.F. The distribution of multiple sclerosis and other diseases. Acta. Neurol. Scand. 1966, 42:221-243.
57. Kurtzke J.F., Beebe G.W., Norman J.E. Epidemiology of multiple sclerosis in U.S. veterans III. Migration and the risk of MS. Neurology 1985, 35:672-678.
58. Kurtzke J.F., Kurland L.T., Goldberg I.D. Mortality and migration in multiple sclerosis. Neurology 1971, 21:1186-1197.
59. Lang H.L., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., Hjorth P., Sondergaard L., Svejgaard A., Wucherpfennig K., Stuart D.I., Bell J.I., Jones E.Y., Fugger L. A functional and structural bases for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 2002, 3:940-943.
60. LaPorte R.E., Tajima N., Dornan J.S., Cruickshanks K.J., Eberhardt M.S., Rabin B.S., Atkinson R.W., Wagener D.K., Becker D.J., Orchard T.J., et al. Differences between blacks and whites in the epidemiology of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania. Am. J. Epidemiol. 1986, 123:592-603.
61. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spegelman D., Ascherio A. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005, 293:2496-2500.
62. Levin L.I., Munger K.L., O'Reilly E.J., Falk K.I., Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 2010, 67:824-830.
63. Ljungkrantz M.E., Ludvigsson J., Samuelsson U. Type 1 diabetes: increased height and weight gains in early childhood. Pediatr. Diabetes 2008, 9(3 Pt 2):50-56.
64. Lonergan R., Kinsella K., Fitzpatrick P., Brady J., Murray B., Dunne C., Hagan R., Duggan M., Jordan S., McKenna M., Hutchinson M., Tubring N. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J. Neurol. Neurosurg. Psychiatry 2011, 82:317-322.
65. Lucas R.M., Hughes A.M., Lay M.L., Ponsonby A.L., Dwyer D.E., Taylor B.V., Pender M.P. Epstein-Barr virus and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2011, 82:1142-1148.
66. Lunemann J.D., Tintore M., Messmer B., Strowig T., Rovira A. Elevated Epstein-Barr Virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann. Neurol. 2010, 67:159-160.
67. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., Munz C. EBNA-1 specific T cells from patients with multiple sclerosis cross react with myelin antigen and co-produce IFN-gamma and IL-2. J. Exp. Med. 2008, 205:1763-1773.
68. Mackay R.P., Myrianthopoulos N.C. Multiple sclerosis in twins and their relatives. Arch. Neurol. 1966, 15:449-462.
69. Mcleod J.G., Hammond S.R., Kurtzke J.F. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration. J. Neurol. 2011, 258:1140-1149.
70. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis. Am. J. Epidemiol. 2009, 169:1260-1266.
71. Mohr S.B., Garland C.F., Gorham E.D., Garland F.C. The association between ultraviolet B irradiance, vitamin D status and incidence of type 1 diabetes in 51 regions worldwide. Diabetologia 2008, 51:1391-1398.
72. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydoxyvitamin D and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
73. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
74. Munz C., Lunemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat. Rev. Immunol. 2009, 9:246-258.
75. Nielsen T.R., Rostgaard K., Askling J., Steffensen R., Oturai A., Jersild C., Koch-Henriksen N., Sorensen P.S., Hjalgrim H. Effects of infectious mononucleosis and HLA-DRB1 15 in multiple sclerosis. Mult. Scler. 2009, 15:431-436.
76. Oberste M.S., Pallansch M.A. Establishing evidence for enterovirus infection in chronic disease. Ann. N. Y. Acad. Sci. 2003, 1005:23-31.
77. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J. Neurol. 2009, 256:1468-1479.
78. Pierrot-Deseilligny C., Souberbielle J.-C. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain 2010, 133:1869-1888.
79. Pohl D., Krane G., Rostasy K., Kahler E., Brunner E., Lehnert M., Wagner H.J., Gärtner J., Hanefeld F. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006, 67:2063-2065.
80. Ponsonby A.L., Lucas R.M., van der Mei I.A. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 2005, 81:1267-1275.
81. Ponsonby A.L., McMichael A., van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiologic research. Toxicology 2002, 181-182:71-78.
82. Pundziute-Lycka A., Urbonaite B., Ostrauskas R., Zalinkevicius R., Dahlquist G.G. Incidence of Type 1 diabetes in Lithuanians aged 0-39 years varies by the urban-rural setting, and the time change differs for men and women during 1991-2000. Diabetes Care 2003, 26:671-676.
83. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., Deluca G.C., Herrera B.M., Chao M.J., Sadovnick A.D., Ebers G.C., Knight J.C. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1 1501 is regulated by vitamin D. PLoS Genet. 2009, 5(2):e1000369.
84. Rothman K.J. Causes. Am. J. Epidemiol. 1976, 104:587-592.
85. Rous P. Viruses and tumor causation. An appraisal of present knowledge. Nature 1965, 207:457-463.
86. Rowe P.C., Valle D., Brusilow S.W. Inborn errors of metabolism in children referred with Reye's syndrome. A changing pattern. JAMA 1988, 260:3167-3170.
87. Sadovnick A.D., Duquette Pl., Herrera B., Yee M., Ebers G.C. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 2007, 69:60-62.
88. Salahuddin S.Z., Ablashi D.V., Markham P.D., Josephs S.F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B., Gallo R.C. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986, 234:596-601.
89. Salvi F., Bartolomie I., Smolensky M.H., Lorusso A., Barbarossa E., Malagoni A.M., Zaboni P., Manfredini R. A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy. BMC Neurol. 2010, 1(10):105.
90. (SEARCH) The Writing Group for the SEARCH for Diabetes in Youth Study Group Incidence of diabetes in youth in the United States. JAMA 2007, 297:2716-2724.
91. Silva A.M., Bettencourt A., Pereira C., Santos E., Carvalho C., Mendonca D., Coasta P.P., Monteiro L., Martins B. Protective role of the HLA-A 02 allele in Portuguese patients with multiple sclerosis. Mult. Scler. 2009, 15:771-774.
92. Simpson S., Blizzard L., Otahal P., Van der Mei I., Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J. Neurol. Neurosurg. Psychiatry 2011, 2011 April 8 [Epub ahead of print].
93. Sumaya C.V., Myers L.W., Ellison G.W. Epstein-Barr virus antibodies in multiple sclerosis. Arch. Neurol. 1980, 37:94-96.
94. Sundstro M.P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nystrom L., Dillner J., Forsgren L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004, 62:2277-2282.
95. Templer D.I., Trent N.H., Spencer D.A., Trent A., Corgiat M.D., Mortensen P.B., Gorton M. Season of birth in multiple sclerosis. Acta Neurol. Scand. 1992, 85:107-109.
96. Thunander M., Petersson C., Jonzon K., Fornander J., Ossiansson B., Torn C., Edvardsson S., Landin-Olsson M. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res. Clin. Pract. 2008, 82:247-255.
97. Virtanen S.M., Knip M. Nutritional risk predictors of (cell autoimmunity and type 1 diabetes at a young age. Am. J. Clin. Nutr. 2003, 78:1053-1067.
98. Voumvourakis K.I., Kitsos D.K., Tsiodras S., Petrikkos G., Stamboulis E. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin. Proc. 2010, 85(11):1023-1030.
99. Weinshenker B.G., Bass B., Rice G.P., Noseworthy J., Carriere W., Baskerville J., Ebers G.C. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989, 112(Pt. 1):133-146.
100. Willer C.J., Dyment D.A., Sadovnick A.D., Rothwell P.M., Murray T.J., Ebers G.C. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005, 330(7483):120. Canadian Collaborative Study Group.
101. Yeung W-C.G., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br. Med. J. 2011, 342:d35. 10.1136/bmld35.
102. Yoon J.W., Austin M., Onodera T., Notkins A.L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis, (virus induced diabetes mellitus). N. Engl. J. Med. 1979, 300:1173-1179.